1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New Jersey >
  6. HotSpot Therapeutics Acquires Macroceutics

M&A Deal Summary

HotSpot Therapeutics Acquires Macroceutics

On August 23, 2019, HotSpot Therapeutics acquired life science company Macroceutics

Acquisition Highlights
  • This is HotSpot Therapeutics’ 1st transaction in the Life Science sector.
  • This is HotSpot Therapeutics’ 1st transaction in the United States.
  • This is HotSpot Therapeutics’ 1st transaction in New Jersey.

M&A Deal Summary
Date 2019-08-23
Target Macroceutics
Sector Life Science
Buyer(s) HotSpot Therapeutics
Deal Type Add-on Acquisition

Target

Macroceutics

Monmouth Junction, New Jersey, United States
Macroceutics, Inc. is a developer of high-quality DNA-Encoded Libraries (DELs) of diverse and drug-like compounds for screening against biological targets. Macroceutics was formed in 2014 and is based in Monmouth Junction, New Jersey.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

HotSpot Therapeutics

Boston, Massachusetts, United States
Category Company
Founded 2017
Sector Life Science
DESCRIPTION

HotSpot Therapeutics is a biotechnology company focused on discovering nature’s regulatory sites to advance allosteric drug discovery. HotSpot Therapeutics was formed in 2017 and is based in Boston, Massachusetts.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: New Jersey M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2019 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal